Celecoxib + Pregabalin for Managing Postoperative Analgesia in Patients Undergoing TKA
Celecoxib + Pregabalin for Managing Postoperative Analgesia in Patients Undergoing TKA
Positive Preemptive Analgesia Effectiveness of Pregabalin Combined with Celecoxib in Total Knee Arthroplasty: A Prospective Controlled Randomized Study.
Pain Res Manag . 2023 Jan 12:2023:7088004.Synopsis
160 patients with knee osteoarthritis, undergoing total knee arthroplasty were randomized to receive either pregabalin + celecoxib (n=40), celecoxib alone (n=40), pregabalin alone (n=40), or placebo (n=40). Outcomes of interest included pain at rest and with movement on a Visual Analog Scale (VAS), sufentanil cumulative dose, high-sensitivity C-reactive protein (hs-CRP), range of motion (ROM), and...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.